Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Autoreactive, Low-Affinity T Cells Preferentially Drive Differentiation of Short-Lived Memory B Cells at the Expense of Germinal Center Maintenance.

Rajiv W Jain | Kate A Parham | Yodit Tesfagiorgis | Heather C Craig | Emiliano Romanchik | Steven M Kerfoot
Cell reports | 2018

B cell fate decisions within a germinal center (GC) are critical to determining the outcome of the immune response to a given antigen. Here, we characterize GC kinetics and B cell fate choices in a response to the autoantigen myelin oligodendrocyte glycoprotein (MOG) and compare the response with a standard model foreign antigen. Both antigens generate productive primary responses, as evidenced by GC development, circulating antigen-specific antibodies, and differentiation of memory B cells. However, in the MOG response, the status of the cognate T cell partner drives preferential B cell differentiation to a memory phenotype at the expense of GC maintenance, resulting in a truncated GC. Reduced plasma cell differentiation is largely independent of T cell influence. Interestingly, memory-phenotype B cells formed in the MOG GC are not long lived, resulting in a failure of the B cell response to secondary challenge.

Pubmed ID: 30566861

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Bcl-6 (antibody)

RRID:AB_10898007

This monoclonal targets Bcl-6

View all literature mentions

Bcl-6 (antibody)

RRID:AB_10926203

This monoclonal targets Bcl-6

View all literature mentions

Purified anti-His Tag (antibody)

RRID:AB_11204080

This monoclonal targets His Tag

View all literature mentions

CD138 (antibody)

RRID:AB_394999

This monoclonal targets CD138

View all literature mentions

CD19 (antibody)

RRID:AB_2738035

This monoclonal targets CD19

View all literature mentions

IgG1 (antibody)

RRID:AB_393553

This monoclonal targets IgG1

View all literature mentions

CD138 (Syndecan-1) (antibody)

RRID:AB_2739663

This monoclonal targets CD138 (Syndecan-1)

View all literature mentions

CD62L (antibody)

RRID:AB_1645210

This monoclonal targets CD62L

View all literature mentions

CD80 (antibody)

RRID:AB_395039

This monoclonal targets CD80

View all literature mentions

Streptavidin-Allophycocyanin-Cy7 (antibody)

RRID:AB_10054651

This unknown targets Streptavidin-Allophycocyanin-Cy7

View all literature mentions